These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 29942117)

  • 1. Icariside II ameliorates endothelial dysfunction by regulating the MAPK pathway via miR-126/SPRED1 in diabetic human cavernous endothelial cells.
    Lei H; Li H; Tian L; Li M; Xin Z; Zhang X; Guan R
    Drug Des Devel Ther; 2018; 12():1743-1751. PubMed ID: 29942117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Icariside II prevents high-glucose-induced injury on human cavernous endothelial cells through Akt-eNOS signaling pathway.
    Li H; Xu Y; Guan R; Matheu M; Lei H; Tian W; Gao Z; Lin G; Guo Y; Xin Z; Song W
    Andrology; 2015 Mar; 3(2):408-16. PubMed ID: 25641754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial dysfunction in patients with chronic kidney disease results from advanced glycation end products (AGE)-mediated inhibition of endothelial nitric oxide synthase through RAGE activation.
    Linden E; Cai W; He JC; Xue C; Li Z; Winston J; Vlassara H; Uribarri J
    Clin J Am Soc Nephrol; 2008 May; 3(3):691-8. PubMed ID: 18256374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of icariside II on improving erectile function in rats with streptozotocin-induced diabetes.
    Zhou F; Xin H; Liu T; Li GY; Gao ZZ; Liu J; Li WR; Cui WS; Bai GY; Park NC; Xin ZC
    J Androl; 2012; 33(5):832-44. PubMed ID: 22403279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-199a-3p and MicroRNA-199a-5p Take Part to a Redundant Network of Regulation of the NOS (NO Synthase)/NO Pathway in the Endothelium.
    Joris V; Gomez EL; Menchi L; Lobysheva I; Di Mauro V; Esfahani H; Condorelli G; Balligand JL; Catalucci D; Dessy C
    Arterioscler Thromb Vasc Biol; 2018 Oct; 38(10):2345-2357. PubMed ID: 29976767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial microparticle-mediated transfer of MicroRNA-126 promotes vascular endothelial cell repair via SPRED1 and is abrogated in glucose-damaged endothelial microparticles.
    Jansen F; Yang X; Hoelscher M; Cattelan A; Schmitz T; Proebsting S; Wenzel D; Vosen S; Franklin BS; Fleischmann BK; Nickenig G; Werner N
    Circulation; 2013 Oct; 128(18):2026-38. PubMed ID: 24014835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycated serum albumin stimulates expression of endothelial cell specific molecule-1 in human umbilical vein endothelial cells: Implication in diabetes mediated endothelial dysfunction.
    Nirala BK; Perumal V; Gohil NK
    Diab Vasc Dis Res; 2015 Jul; 12(4):290-7. PubMed ID: 25963575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antioxidant icariside II combined with insulin restores erectile function in streptozotocin-induced type 1 diabetic rats.
    Wang L; Xu Y; Li H; Lei H; Guan R; Gao Z; Xin Z
    J Cell Mol Med; 2015 May; 19(5):960-9. PubMed ID: 25781208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced glycation end products increase expression of S100A8 and A9 via RAGE-MAPK in rat dental pulp cells.
    Nakajima Y; Inagaki Y; Kido J; Nagata T
    Oral Dis; 2015 Apr; 21(3):328-34. PubMed ID: 25098709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced glycation end products of bovine serum albumin affect the cell growth of human umbilical vein endothelial cells via modulation of MEG3/miR-93/p21 pathway.
    Ju C; Sheng Z; Wang Q; Li Y; Wang X; Li S; Qi Q; Yuan Z
    Acta Biochim Biophys Sin (Shanghai); 2019 Jan; 51(1):41-50. PubMed ID: 30544204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced-glycation-end-product-cholesterol-aggregated-protein accelerates the proliferation of mesangial cells mediated by transforming-growth-factor-beta 1 receptors and the ERK-MAPK pathway.
    Hirasawa Y; Sakai T; Ito M; Yoshimura H; Feng Y; Nagamatsu T
    Eur J Pharmacol; 2011 Dec; 672(1-3):159-68. PubMed ID: 21989075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-21-3p regulates AGE/RAGE signalling and improves diabetic atherosclerosis.
    Shao M; Yu M; Zhao J; Mei J; Pan Y; Zhang J; Wu H; Yu M; Liu F; Chen G
    Cell Biochem Funct; 2020 Oct; 38(7):965-975. PubMed ID: 32196704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced glycation end-products decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells.
    Ren X; Ren L; Wei Q; Shao H; Chen L; Liu N
    Cardiovasc Diabetol; 2017 Apr; 16(1):52. PubMed ID: 28427390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced glycation end products of bovine serum albumin-induced endothelial-to-mesenchymal transition in cultured human and monkey endothelial cells via protein kinase B signaling cascades.
    Ma J; Liu T; Dong X
    Mol Vis; 2010 Dec; 16():2669-79. PubMed ID: 21179235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrine-Type Alkaloids Inhibit Advanced Glycation End Products Induced Reactive Oxygen Species-Mediated Apoptosis of Aortic Endothelial Cells In Vivo and In Vitro by Targeting MKK3 and p38MAPK Signaling.
    Liu Z; Lv Y; Zhang Y; Liu F; Zhu L; Pan S; Qiu C; Guo Y; Yang T; Wang J
    J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29197828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human endothelial cell nitric oxide synthesis by advanced glycation end-products but not glucose: relevance to diabetes.
    Xu B; Ji Y; Yao K; Cao YX; Ferro A
    Clin Sci (Lond); 2005 Nov; 109(5):439-46. PubMed ID: 16022682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shixiang Plaster, a Traditional Chinese Medicine, Promotes Healing in a Rat Model of Diabetic Ulcer Through the receptor for Advanced Glycation End Products (RAGE)/Nuclear Factor kappa B (NF-κB) and Vascular Endothelial Growth Factor (VEGF)/Vascular Cell Adhesion Molecule-1 (VCAM-1)/Endothelial Nitric Oxide Synthase (eNOS) Signaling Pathways.
    Fei J; Ling YM; Zeng MJ; Zhang KW
    Med Sci Monit; 2019 Dec; 25():9446-9457. PubMed ID: 31825949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced glycation end products impair the functions of saphenous vein but not thoracic artery smooth muscle cells through RAGE/MAPK signalling pathway in diabetes.
    Sun Y; Kang L; Li J; Liu H; Wang Y; Wang C; Zou Y
    J Cell Mol Med; 2016 Oct; 20(10):1945-55. PubMed ID: 27297874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced glycation end products upregulate lysyl oxidase and endothelin-1 in human aortic endothelial cells via parallel activation of ERK1/2-NF-κB and JNK-AP-1 signaling pathways.
    Adamopoulos C; Piperi C; Gargalionis AN; Dalagiorgou G; Spilioti E; Korkolopoulou P; Diamanti-Kandarakis E; Papavassiliou AG
    Cell Mol Life Sci; 2016 Apr; 73(8):1685-98. PubMed ID: 26646068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of P38MAPK in human corneal endothelial cell migration induced by TGF-β(2).
    Joko T; Shiraishi A; Akune Y; Tokumaru S; Kobayashi T; Miyata K; Ohashi Y
    Exp Eye Res; 2013 Mar; 108():23-32. PubMed ID: 23257207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.